Literature DB >> 6116756

An analysis of the mechanism of 5-hydroxytryptamine-induced vasopressor responses in ganglion-blocked anaesthetized dogs.

W Feniuk, J Hare, P P Humphrey.   

Abstract

5-Hydroxytryptamine (5-HT) administered intravenously (i.v., 1--30 micrograms kg-1) to ganglion-blocked anaesthetized dogs produced dose-related increases in diastolic blood pressure and we have analysed the mechanism involved. Cyproheptadine and methysergide (10--100 micrograms kg-1 i.v.) were potent and specific antagonists of the 5-HT induced rise in blood pressure, while the alpha-adrenoceptor blocking agent phentolamine (0.3--3 mg kg-1 i.v.) also caused dose-related inhibition. Syrosingopine pretreatment converted the vasopressor action of 5-HT to a vasodepressor action and acute bilateral adrenalectomy caused a marked reduction in the 5-HT-induced rise in blood pressure. In two dogs, 5-HT (30 micrograms kg-1 i.v.) markedly increased the venous plasma concentrations of noradrenaline and adrenaline. We concluded that the 5-HT-induced rise in diastolic pressure in the ganglion blocked anaesthetized dog is due largely to the release of catecholamines of which a substantial component is from the adrenal gland. The rise in diastolic blood pressure is specifically blocked by low doses of cyproheptadine and methysergide suggesting that the release of catecholamines is mediated by specific 5-HT receptors located mainly within the adrenal medulla.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116756     DOI: 10.1111/j.2042-7158.1981.tb13739.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors.

Authors:  P R Saxena; E J Mylecharane; J Heiligers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

2.  Evidence for 5-HT(1B/1D) and 5-HT(2A) receptors mediating constriction of the canine internal carotid circulation.

Authors:  D Centurión; M I Ortiz; A Sánchez-López; P De Vries; P R Saxena; C M Villalón
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

3.  5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor.

Authors:  A H Bom; D J Duncker; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

4.  The inhibitory effects of 5-hydroxytryptamine on gastric acid secretion by the rat isolated stomach.

Authors:  S P Canfield; J E Spencer
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

5.  Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs.

Authors:  C M Villalón; E Ramírez-San Juan; C Castillo; E Castillo; F J López-Muñoz; J A Terrón
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

6.  The Effects of Tryptophan Enhancement and Depletion on Plasma Catecholamine Levels in Healthy Individuals.

Authors:  Stephen H Boyle; Beverly H Brummett; Cynthia M Kuhn; John C Barefoot; Ilene C Siegler; Redford B Williams; Anastasia Georgiades
Journal:  Psychosom Med       Date:  2019-01       Impact factor: 4.312

7.  Inhibitory 5-hydroxytryptamine receptors involved in pressor effects obtained by stimulation of sympathetic outflow from spinal cord in pithed rats.

Authors:  A Morán; C Velasco; T Salvador; M L Martín; L San Román
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.